Coagulation disorders during CRS of a BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Periodic results of a phase I clinical trial

被引：0
|
作者：
Shao, Mi [1 ]
Hu, Yongxian [1 ]
Xu, Huijun [1 ]
Zhang, Yanlei [1 ]
Cui, Jiazhen [1 ]
Huang, He [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O053
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [31] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [32] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [33] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [34] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [35] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Heng Mei
    Chenggong Li
    Huiwen Jiang
    Xinying Zhao
    Zhiping Huang
    Dan Jin
    Tao Guo
    Haiming Kou
    Lin Liu
    Lu Tang
    Ping Yin
    Zhihui Wang
    Lisha Ai
    Sha Ke
    Yimeng Xia
    Jun Deng
    Lei Chen
    Li Cai
    Chunyan Sun
    Linghui Xia
    Gaoquan Hua
    Yu Hu
    Journal of Hematology & Oncology, 14
  • [36] Outcomes of Anti-BCMA CAR T Cell Therapy for Relapsed/refractory Multiple Myeloma: A Meta-Analysis
    Gagelmann, Nico
    Ayuk, Francis
    Atanackovic, Djordje
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 130 - 130
  • [37] Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
    Sham Mailankody
    Jeffrey V. Matous
    Saurabh Chhabra
    Michaela Liedtke
    Surbhi Sidana
    Olalekan O. Oluwole
    Shahbaz Malik
    Rajneesh Nath
    Faiz Anwer
    Jose Carlos Cruz
    Myo Htut
    Erin E. Karski
    Wade Lovelace
    Myles Dillon
    Eric Butz
    Wendy Ying
    Arun Balakumaran
    Shaji K. Kumar
    Nature Medicine, 2023, 29 : 3271 - 3271
  • [38] A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial
    Li, Chenggong
    Mei, Heng
    Hu, Yu
    Guo, Tao
    Liu, Lin
    Jiang, Huiwen
    Tang, Lu
    Wu, Yaohui
    Ai, Lisha
    Deng, Jun
    Jin, Dan
    BLOOD, 2019, 134
  • [39] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [40] bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study.
    Raje, Noopur S.
    Berdeja, Jesus G.
    Lin, Yi
    Munshi, Nikhil C.
    Samuel, David
    Siegel, DiCapua
    Liedtke, Michaela
    Jagannath, Sundar
    Madduri, Deepu
    Rosenblatt, Jacalyn
    Maus, Marcela Valderrama
    Turka, Ashley
    Lam, Lyh Ping
    Morgan, Richard A.
    Quigley, Travis
    Massaro, Monica
    Hege, Kristen
    Petrocca, Fabio
    Kochenderfer, James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345